An error occurred retrieving publication content to display, please try again.
Page not found (404)
Sorry - the page you requested could not be found.
Please choose a page from the navigation or try a website search above to find the information you need.
Toolkit
New evidence supported existing evidence of some benefit from AchEIs for Alzheimer's disease. There was weaker evidence for benefit from memantine. Cost-effectiveness estimates are highly uncertain and very sensitive to change.
1 Peninsula Technology Assessment Group (PenTAG), University of Exeter, Exeter, UK
2 London School of Hygiene and Tropical Medicine, London, UK
3 The School of Health and Related Research (ScHARR), University of Sheffield, Sheffield, UK
4 Royal Devon and Exeter Foundation Trust Hospital, Exeter, UK
* Corresponding author Email: mary.bond@pms.ac.uk
Funding: {{metadata.Funding}}
{{metadata.Journal}} Volume: {{metadata.Volume}}, Issue: {{metadata.Issue}}, Published in {{metadata.PublicationDate | date:'MMMM yyyy'}}
https://doi.org/{{metadata.DOI}}
Citation:{{author}}{{ (($index < metadata.AuthorsArray.length-1) && ($index <=6)) ? ', ' : '' }}{{(metadata.AuthorsArray.length <= 6) ? '.' : '' }} {{(metadata.AuthorsArray.length > 6) ? 'et al. ' : ''}}. {{metadata.JournalShortName}} {{metadata.PublicationDate | date:'yyyy'}};{{metadata.Volume}}({{metadata.Issue}})
Report Content
The full text of this issue is available as a PDF document from the Toolkit section on this page.
The full text of this issue is available as a PDF document from the Toolkit section on this page.
Responses to this report
No responses have been published.
An error has occurred in processing the XML document